ATE404187T1 - Verwendung von idrocilamid zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von rosacea - Google Patents

Verwendung von idrocilamid zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von rosacea

Info

Publication number
ATE404187T1
ATE404187T1 AT04805440T AT04805440T ATE404187T1 AT E404187 T1 ATE404187 T1 AT E404187T1 AT 04805440 T AT04805440 T AT 04805440T AT 04805440 T AT04805440 T AT 04805440T AT E404187 T1 ATE404187 T1 AT E404187T1
Authority
AT
Austria
Prior art keywords
idrocilamide
treatment
rosacea
preparing
pharmaceutical composition
Prior art date
Application number
AT04805440T
Other languages
English (en)
Inventor
Fabrizio Dolfi
William Robert Pilgrim
Original Assignee
Galderma Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Res & Dev filed Critical Galderma Res & Dev
Application granted granted Critical
Publication of ATE404187T1 publication Critical patent/ATE404187T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AT04805440T 2003-11-21 2004-11-10 Verwendung von idrocilamid zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von rosacea ATE404187T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0313666A FR2862538B1 (fr) 2003-11-21 2003-11-21 Utilisation de l'idrocilamide pour la preparation d'une composition pharmaceutique pour le traitement de la rosacee

Publications (1)

Publication Number Publication Date
ATE404187T1 true ATE404187T1 (de) 2008-08-15

Family

ID=34531179

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04805440T ATE404187T1 (de) 2003-11-21 2004-11-10 Verwendung von idrocilamid zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von rosacea

Country Status (8)

Country Link
US (1) US20070269524A1 (de)
EP (1) EP1686978B1 (de)
AT (1) ATE404187T1 (de)
CA (1) CA2545080A1 (de)
DE (1) DE602004015831D1 (de)
ES (1) ES2311874T3 (de)
FR (1) FR2862538B1 (de)
WO (1) WO2005060950A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2040181A1 (de) * 1969-04-02 1971-01-22 Lipha
DE3361275D1 (en) * 1982-05-04 1986-01-02 Lipha Sustained-release theophyllin drug formulation
IL142037A0 (en) * 2001-03-15 2002-03-10 Agis Ind 1983 Ltd Pharmaceutical compositions containing a non-steroidal anti-inflammatory drug
GB0504994D0 (en) * 2005-03-11 2005-04-20 Biotica Tech Ltd Novel compounds
GB0520955D0 (en) * 2005-10-14 2005-11-23 Cyclacel Ltd Compound
US20090221568A1 (en) * 2005-11-04 2009-09-03 Jared Shaw Synthesis of Inhibitors of FtsZ

Also Published As

Publication number Publication date
ES2311874T3 (es) 2009-02-16
DE602004015831D1 (de) 2008-09-25
US20070269524A1 (en) 2007-11-22
WO2005060950A1 (fr) 2005-07-07
EP1686978A1 (de) 2006-08-09
EP1686978B1 (de) 2008-08-13
FR2862538A1 (fr) 2005-05-27
CA2545080A1 (fr) 2005-07-07
FR2862538B1 (fr) 2006-03-03

Similar Documents

Publication Publication Date Title
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
BR0116370A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente.
DE50115490D1 (de) Kosmetische zusammensetzung zur behandlung von alternder und/oder gestresster haut
DE50311898D1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
ATE223215T1 (de) Inhibitoren der fettsäuresynthese als antimikrobielle mittel
BRPI0512253A (pt) composto, formulação farmacêutica, uso de um composto, método de tratamento de uma doença, produto combinado, e, processo para a preparação de um composto
BR0313371A (pt) Composto, uso de um composto e método de tratamento de doença
BR0309278A (pt) Composto, composição, métodos para modular a atividade da cinesina ksp, para inibir a ksp, para o tratamento de uma doença proliferativa celular, e, uso de um composto
DE602005023782D1 (de) Pyrrolidinderivate zur behandlung einer von der reninaktivität abhängigen krankheit
BR0209127A (pt) compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
DE502004008819D1 (de) Medikament zur wachstumsinhibierung von tumoren
CY1111353T1 (el) Χρηση ενωσεων κααλαλιδης για την παραγωγη φαρμακου για τη θεραπεια της ψωριασης
BR0209128A (pt) Compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos
BRPI0507321A (pt) derivados de 7-amino-4-quinolona-3-ácido carboxìlico substituìdos com cicloalquila, processos para produção dos mesmos e uso dos mesmos como medicamento
BRPI0412424A (pt) composto, composição farmacêutica, método para tratar doenças dermatológicas ou cancerosas em um mamìfero, composição, e, método para tratar doenças relacionadas com a pele ou cancerosas
ATE553760T1 (de) Verwendung von alverin zur behandlung von hauterkrankungen
ATE527377T1 (de) Erstellung von genexpressionprofilen aus ffpe- proben
BRPI0411087A (pt) aperfeiçoamentos em ou relacionados a compostos orgánicos
WO2006080043A3 (en) Organic compounds useful for the treatment of alzheimer's disease, their use and method of preparation
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
TNSN06233A1 (en) 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
DE602004019778D1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
ATE404187T1 (de) Verwendung von idrocilamid zur herstellung einer pharmazeutischen zusammensetzung zur behandlung von rosacea
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE602006019842D1 (de) Verwendung von lecithin als arzneimittel zur behandlung von psoriasis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties